Actively Recruiting

Age: 16Years +
All Genders
Healthy Volunteers
ID07477197

Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders

Led by Children's Hospital Medical Center, Cincinnati · Updated on 2026-03-17

5000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are collecting and managing a repository of tissue samples and detailed health information from adults aged 16 and older with congenital heart disease and related conditions. The study aims to support future research on the biological causes of these diseases, how the body compensates or worsens over time, links between clinical features and biomarkers, and factors that predict health outcomes. Control groups include adults without these conditions to provide comparison data. The study involves enrolling adults attending clinical visits at the Heart Institute and potentially other cardiology departments in the future. Data collection includes biospecimens and extensive health information gathered at baseline and repeatedly over time during outpatient visits and procedures. This ongoing approach helps capture changes in health status and patient experiences. Participants will provide samples and information through surveys about symptoms and lifestyle, along with patient-reported outcome measures. The main goal is to establish and maintain a biospecimen repository successfully. Researchers will track the availability of samples over time and collect data longitudinally. The study allows for long-term observation to better understand disease progression and outcomes in these conditions.

CONDITIONS

Brief Title

Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders

Who Can Participate

Age: 16Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 16 years or older suspected or diagnosed with congenital heart disease, pulmonary hypertension, connective tissue disease, or other cardiovascular conditions
  • Control subjects aged 16 years or older who are non-smokers without diabetes, myocardial infarction, stroke, heart failure, or chronic kidney disease
  • Control group participants may be family members, volunteers recruited by advertisement, or others willing to enroll
  • Comparison group of adults aged 16 years or older with heart failure or pulmonary hypertension but without congenital heart disease
Not Eligible

You will not qualify if you...

  • Unable to provide informed consent or assent personally or via a legal guardian
  • Considered unsafe to collect biospecimens by a clinical provider or investigator
  • Hospitalized overnight for a non-obstetric reason and discharged within the prior 30 days

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Sample Collection

Duration - Ongoing throughout participant enrollment and follow-up

Participants provide tissue specimens and biological samples during clinical encounters.

Sequential outpatient visits and procedure encounters

Long-term Monitoring

Duration - Ongoing throughout participant enrollment and follow-up

Participants complete surveys and patient-reported outcome measures on symptoms and lifestyle over time.

Multiple outpatient visits over time

Trial Site Locations

Total: 1 location

1

Children's Hospital Medical Center, Cincinnati

Cincinnati, Ohio, United States, 45229

Actively Recruiting

Loading map...

Research Team

S

Sasha Opotowsky, MD

L

Lindsay Fist

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

129Xenon MR Imaging and Spectroscopy Response to Sotatercept...

Pulmonary Hypertension

Actively Recruiting

1 location

An Open-Label, Phase 2 Study Evaluating the Safety of Moslic...

Pulmonary Hypertension

Actively Recruiting

1 location

A Phase 2, Double-blind, Randomized, Placebo-Controlled Stud...

Pulmonary Hypertension

Actively Recruiting

86 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here